Global Oncology Biosimilars Market Professional Survey Report 2019

Publisher Name :
Date: 23-Sep-2019
No. of pages: 108
Inquire Before Buying

Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry. In the past few years, various biosimilars have been approved by FDA for the treatment of various types of cancer such as blood cancer, colorectal cancer, breast cancer, and others. In the near future, it is expected that a few more biosimilars will be introduced in the market thus supporting the growth of the market.

The global Oncology Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Oncology Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology Biosimilars market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Oncology Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Oncology Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- Celltrion

- Biocon

- Dr. Reddy's Laboratories

- STADA Arzneimittel AG

- Intas Pharmaceuticals

- Pfizer

- Sandoz International

- Teva Pharmaceutical Industries Ltd

- Apotex

- BIOCAD

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- mAb

- Immunomodulators

- Hematopoietic Agents

- G-CSF 

- Others

Segment by Application

- Retail Pharmacies

- Hospital Pharmacy

- Online Pharmacy

Global Oncology Biosimilars Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Oncology Biosimilars
1.1 Definition of Oncology Biosimilars
1.2 Oncology Biosimilars Segment by Type
1.2.1 Global Oncology Biosimilars Production Growth Rate Comparison by Types (2014-2025)
1.2.2 mAb
1.2.3 Immunomodulators
1.2.4 Hematopoietic Agents
1.2.5 G-CSF 
1.2.6 Others
1.3 Oncology Biosimilars Segment by Applications
1.3.1 Global Oncology Biosimilars Consumption Comparison by Applications (2014-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oncology Biosimilars Overall Market
1.4.1 Global Oncology Biosimilars Revenue (2014-2025)
1.4.2 Global Oncology Biosimilars Production (2014-2025)
1.4.3 North America Oncology Biosimilars Status and Prospect (2014-2025)
1.4.4 Europe Oncology Biosimilars Status and Prospect (2014-2025)
1.4.5 China Oncology Biosimilars Status and Prospect (2014-2025)
1.4.6 Japan Oncology Biosimilars Status and Prospect (2014-2025)
1.4.7 Southeast Asia Oncology Biosimilars Status and Prospect (2014-2025)
1.4.8 India Oncology Biosimilars Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.3 Manufacturing Process Analysis of Oncology Biosimilars
2.4 Industry Chain Structure of Oncology Biosimilars
3 Development and Manufacturing Plants Analysis of Oncology Biosimilars
3.1 Capacity and Commercial Production Date
3.2 Global Oncology Biosimilars Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Oncology Biosimilars
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Oncology Biosimilars Production and Capacity Analysis
4.2 Oncology Biosimilars Revenue Analysis
4.3 Oncology Biosimilars Price Analysis
4.4 Market Concentration Degree
5 Oncology Biosimilars Regional Market Analysis
5.1 Oncology Biosimilars Production by Regions
5.1.1 Global Oncology Biosimilars Production by Regions
5.1.2 Global Oncology Biosimilars Revenue by Regions
5.2 Oncology Biosimilars Consumption by Regions
5.3 North America Oncology Biosimilars Market Analysis
5.3.1 North America Oncology Biosimilars Production
5.3.2 North America Oncology Biosimilars Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Oncology Biosimilars Import and Export
5.4 Europe Oncology Biosimilars Market Analysis
5.4.1 Europe Oncology Biosimilars Production
5.4.2 Europe Oncology Biosimilars Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Oncology Biosimilars Import and Export
5.5 China Oncology Biosimilars Market Analysis
5.5.1 China Oncology Biosimilars Production
5.5.2 China Oncology Biosimilars Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Oncology Biosimilars Import and Export
5.6 Japan Oncology Biosimilars Market Analysis
5.6.1 Japan Oncology Biosimilars Production
5.6.2 Japan Oncology Biosimilars Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Oncology Biosimilars Import and Export
5.7 Southeast Asia Oncology Biosimilars Market Analysis
5.7.1 Southeast Asia Oncology Biosimilars Production
5.7.2 Southeast Asia Oncology Biosimilars Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Oncology Biosimilars Import and Export
5.8 India Oncology Biosimilars Market Analysis
5.8.1 India Oncology Biosimilars Production
5.8.2 India Oncology Biosimilars Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Oncology Biosimilars Import and Export
6 Oncology Biosimilars Segment Market Analysis (by Type)
6.1 Global Oncology Biosimilars Production by Type
6.2 Global Oncology Biosimilars Revenue by Type
6.3 Oncology Biosimilars Price by Type
7 Oncology Biosimilars Segment Market Analysis (by Application)
7.1 Global Oncology Biosimilars Consumption by Application
7.2 Global Oncology Biosimilars Consumption Market Share by Application (2014-2019)
8 Oncology Biosimilars Major Manufacturers Analysis
8.1 Celltrion
8.1.1 Celltrion Oncology Biosimilars Production Sites and Area Served
8.1.2 Celltrion Product Introduction, Application and Specification
8.1.3 Celltrion Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biocon
8.2.1 Biocon Oncology Biosimilars Production Sites and Area Served
8.2.2 Biocon Product Introduction, Application and Specification
8.2.3 Biocon Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Dr. Reddy's Laboratories
8.3.1 Dr. Reddy's Laboratories Oncology Biosimilars Production Sites and Area Served
8.3.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
8.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 STADA Arzneimittel AG
8.4.1 STADA Arzneimittel AG Oncology Biosimilars Production Sites and Area Served
8.4.2 STADA Arzneimittel AG Product Introduction, Application and Specification
8.4.3 STADA Arzneimittel AG Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Intas Pharmaceuticals
8.5.1 Intas Pharmaceuticals Oncology Biosimilars Production Sites and Area Served
8.5.2 Intas Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Intas Pharmaceuticals Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer
8.6.1 Pfizer Oncology Biosimilars Production Sites and Area Served
8.6.2 Pfizer Product Introduction, Application and Specification
8.6.3 Pfizer Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sandoz International
8.7.1 Sandoz International Oncology Biosimilars Production Sites and Area Served
8.7.2 Sandoz International Product Introduction, Application and Specification
8.7.3 Sandoz International Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Teva Pharmaceutical Industries Ltd
8.8.1 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production Sites and Area Served
8.8.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Apotex
8.9.1 Apotex Oncology Biosimilars Production Sites and Area Served
8.9.2 Apotex Product Introduction, Application and Specification
8.9.3 Apotex Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 BIOCAD
8.10.1 BIOCAD Oncology Biosimilars Production Sites and Area Served
8.10.2 BIOCAD Product Introduction, Application and Specification
8.10.3 BIOCAD Oncology Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Oncology Biosimilars Market
9.1 Global Oncology Biosimilars Market Trend Analysis
9.1.1 Global Oncology Biosimilars Market Size (Volume and Value) Forecast 2019-2025
9.2 Oncology Biosimilars Regional Market Trend
9.2.1 North America Oncology Biosimilars Forecast 2019-2025
9.2.2 Europe Oncology Biosimilars Forecast 2019-2025
9.2.3 China Oncology Biosimilars Forecast 2019-2025
9.2.4 Japan Oncology Biosimilars Forecast 2019-2025
9.2.5 Southeast Asia Oncology Biosimilars Forecast 2019-2025
9.2.6 India Oncology Biosimilars Forecast 2019-2025
9.3 Oncology Biosimilars Market Trend (Product Type)
9.4 Oncology Biosimilars Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Oncology Biosimilars Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Oncology Biosimilars
Table Global Oncology Biosimilars Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Oncology Biosimilars Production Market Share by Types in 2018
Figure mAb Product Picture
Figure Immunomodulators Product Picture
Figure Hematopoietic Agents Product Picture
Figure G-CSF  Product Picture
Figure Others Product Picture
Table Global Oncology Biosimilars Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Oncology Biosimilars Consumption Market Share by Applications in 2018
Figure Retail Pharmacies
Figure Hospital Pharmacy
Figure Online Pharmacy
Figure Global Oncology Biosimilars Revenue (Million USD) (2014-2025)
Figure Global Oncology Biosimilars Production (K Units) (2014-2025)
Figure North America Oncology Biosimilars Market Size (Million USD) (2014-2025)
Figure Europe Oncology Biosimilars Market Size (Million USD) (2014-2025)
Figure China Oncology Biosimilars Market Size (Million USD) (2014-2025)
Figure Japan Oncology Biosimilars Market Size (Million USD) (2014-2025)
Figure Southeast Asia Oncology Biosimilars Market Size (Million USD) (2014-2025)
Figure India Oncology Biosimilars Market Size (Million USD) (2014-2025)
Table Oncology Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oncology Biosimilars in 2018
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Industry Chain Structure of Oncology Biosimilars
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Oncology Biosimilars Manufacturing Plants Distribution
Table Oncology Biosimilars Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Oncology Biosimilars Capacity (K Units) of Major Manufacturers (2014-2019)
Table Oncology Biosimilars Production (K Units) of Major Manufacturers (2014-2019)
Table Oncology Biosimilars Production Market Share of Major Manufacturers (2014-2019)
Figure Oncology Biosimilars Production Share by Manufacturers in 2018
Table Oncology Biosimilars Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Oncology Biosimilars Revenue Market Share of Major Manufacturers (2014-2019)
Figure Oncology Biosimilars Revenue Share by Manufacturers in 2018
Table Oncology Biosimilars Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Oncology Biosimilars Production by Regions 2014-2019 (K Units)
Table Global Oncology Biosimilars Production Market Share by Regions 2014-2019
Figure Global Oncology Biosimilars Production Market Share by Regions in 2018
Table Global Oncology Biosimilars Revenue by Regions 2014-2019 (Million USD)
Table Global Oncology Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2018
Table Global Oncology Biosimilars Consumption by Regions 2014-2019 (K Units)
Table Global Oncology Biosimilars Consumption Market Share by Regions 2014-2019
Figure North America Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure North America Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table North America Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure Europe Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure Europe Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure China Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure China Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table China Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure Japan Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure Japan Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure Southeast Asia Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure India Oncology Biosimilars Production Growth Rate 2014-2019 (K Units)
Figure India Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table India Oncology Biosimilars Production, Consumption Import and Export (K Units)
Figure Global Consumption Oncology Biosimilars Market Share by Application (2014-2019)
Figure Global Value (Consumption) Oncology Biosimilars Market Share by Application (2014-2019)
Table Celltrion Oncology Biosimilars Production Sites and Area Served
Table Celltrion Oncology Biosimilars Product Introduction, Application and Specification
Table Celltrion Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Oncology Biosimilars Production Growth Rate (2014-2019)
Table Celltrion Oncology Biosimilars Production Market Share (2014-2019)
Figure Celltrion Oncology Biosimilars Revenue Market Share (2014-2019)
Table Celltrion Oncology Biosimilars Main Business and Markets Served
Table Biocon Oncology Biosimilars Production Sites and Area Served
Table Biocon Oncology Biosimilars Product Introduction, Application and Specification
Table Biocon Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Oncology Biosimilars Production Growth Rate (2014-2019)
Table Biocon Oncology Biosimilars Production Market Share (2014-2019)
Figure Biocon Oncology Biosimilars Revenue Market Share (2014-2019)
Table Biocon Oncology Biosimilars Main Business and Markets Served
Table Dr. Reddy's Laboratories Oncology Biosimilars Production Sites and Area Served
Table Dr. Reddy's Laboratories Oncology Biosimilars Product Introduction, Application and Specification
Table Dr. Reddy's Laboratories Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Oncology Biosimilars Production Growth Rate (2014-2019)
Table Dr. Reddy's Laboratories Oncology Biosimilars Production Market Share (2014-2019)
Figure Dr. Reddy's Laboratories Oncology Biosimilars Revenue Market Share (2014-2019)
Table Dr. Reddy's Laboratories Oncology Biosimilars Main Business and Markets Served
Table STADA Arzneimittel AG Oncology Biosimilars Production Sites and Area Served
Table STADA Arzneimittel AG Oncology Biosimilars Product Introduction, Application and Specification
Table STADA Arzneimittel AG Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table STADA Arzneimittel AG Oncology Biosimilars Production Growth Rate (2014-2019)
Table STADA Arzneimittel AG Oncology Biosimilars Production Market Share (2014-2019)
Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Market Share (2014-2019)
Table STADA Arzneimittel AG Oncology Biosimilars Main Business and Markets Served
Table Intas Pharmaceuticals Oncology Biosimilars Production Sites and Area Served
Table Intas Pharmaceuticals Oncology Biosimilars Product Introduction, Application and Specification
Table Intas Pharmaceuticals Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Intas Pharmaceuticals Oncology Biosimilars Production Growth Rate (2014-2019)
Table Intas Pharmaceuticals Oncology Biosimilars Production Market Share (2014-2019)
Figure Intas Pharmaceuticals Oncology Biosimilars Revenue Market Share (2014-2019)
Table Intas Pharmaceuticals Oncology Biosimilars Main Business and Markets Served
Table Pfizer Oncology Biosimilars Production Sites and Area Served
Table Pfizer Oncology Biosimilars Product Introduction, Application and Specification
Table Pfizer Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Oncology Biosimilars Production Growth Rate (2014-2019)
Table Pfizer Oncology Biosimilars Production Market Share (2014-2019)
Figure Pfizer Oncology Biosimilars Revenue Market Share (2014-2019)
Table Pfizer Oncology Biosimilars Main Business and Markets Served
Table Sandoz International Oncology Biosimilars Production Sites and Area Served
Table Sandoz International Oncology Biosimilars Product Introduction, Application and Specification
Table Sandoz International Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz International Oncology Biosimilars Production Growth Rate (2014-2019)
Table Sandoz International Oncology Biosimilars Production Market Share (2014-2019)
Figure Sandoz International Oncology Biosimilars Revenue Market Share (2014-2019)
Table Sandoz International Oncology Biosimilars Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Oncology Biosimilars Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Main Business and Markets Served
Table Apotex Oncology Biosimilars Production Sites and Area Served
Table Apotex Oncology Biosimilars Product Introduction, Application and Specification
Table Apotex Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Apotex Oncology Biosimilars Production Growth Rate (2014-2019)
Table Apotex Oncology Biosimilars Production Market Share (2014-2019)
Figure Apotex Oncology Biosimilars Revenue Market Share (2014-2019)
Table Apotex Oncology Biosimilars Main Business and Markets Served
Table BIOCAD Oncology Biosimilars Production Sites and Area Served
Table BIOCAD Oncology Biosimilars Product Introduction, Application and Specification
Table BIOCAD Oncology Biosimilars Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOCAD Oncology Biosimilars Production Growth Rate (2014-2019)
Table BIOCAD Oncology Biosimilars Production Market Share (2014-2019)
Figure BIOCAD Oncology Biosimilars Revenue Market Share (2014-2019)
Table BIOCAD Oncology Biosimilars Main Business and Markets Served
Figure Global Oncology Biosimilars Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Oncology Biosimilars Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Oncology Biosimilars Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Oncology Biosimilars Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Oncology Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Oncology Biosimilars by Type (2019-2025)
Table Global Consumption (K Units) of Oncology Biosimilars by Application (2019-2025)
Table Oncology Biosimilars Distributors List
Table Oncology Biosimilars Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Oncology Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 07-Dec-2019        Price: US 3300 Onwards        Pages: 119
    Summary The report forecast global Oncology Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Oncology Biosimilars industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncology Biosimilars by geography. The report splits the market size, by volume an......
  • Global Follow-On-Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 137
    The Follow-On-Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the Follow-On-Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancem......
  • Global Biologics and Biosimilars Market Growth 2019-2024
    Published: 28-Nov-2019        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Biologics and Biosimilars market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 256540 million by 2024, from US$ 214000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biologics and Biosimilars business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biologics......
  • 2017-2025 World Oncology Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 26-Nov-2019        Price: US 2800 Onwards        Pages: 102
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global total and......
  • Global Biologics and Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 22-Nov-2019        Price: US 3300 Onwards        Pages: 166
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Adalimumab Biosimilar Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • Global Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 132
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The report forecast global Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Biosimilars industry and main market trends. The market research......
  • Global Biologics and Biosimilars Market Study 2016-2026, by Segment (Antibody, Hormone,) , by Market (Tumor, Diabetes,) , by Company (Roche, Amgen,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 65
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Biosimilars Market Study 2016-2026, by Segment (Injection, Tablets,) , by Market (Ankylosing Spondylitis, Tumor,) , by Company (Sandoz International, Hospira,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The global Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Injection - Tablets - Others......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs